Search

everythinglearnresearchcommunity

for

Search:↓

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Women with PCOS have more emotional and body image issues than healthy women.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

People undergoing chemotherapy need better support and information to cope with hair loss.